ProcM-like enzymes are class II promiscuous lanthipeptide
synthetases
that are an attractive tool in synthetic biology for producing lanthipeptides
with biotechnological or clinically desired properties. SyncM is a
recently described modification enzyme from this family used to develop
a versatile expression platform for engineering lanthipeptides. Most
remarkably, SyncM can modify up to 79 SyncA substrates in a single
strain. Six SyncAs were previously characterized from this pool of
substrates. They showed particular characteristics, such as the presence
of one or two lanthionine rings, different flanking residues influencing
ring formation, and different ring directions, demonstrating the relaxed
specificity of SyncM toward its precursor peptides. To gain a deeper
understanding of the potential of SyncM as a biosynthetic tool, we
further explored the enzyme′s capabilities and limits in dehydration
and ring formation. We used different SyncA scaffolds for peptide
engineering, including changes in the ring′s directionality
(relative position of Ser/Thr to Cys in the peptide) and size. We
further aimed to rationally design mimetics of cyclic antimicrobials
and introduce macrocycles in prochlorosin-related and nonrelated substrates.
This study highlights the largest lanthionine ring with 15 amino acids
(ring-forming residues included) described to date. Taking advantage
of the amino acid substrate tolerance of SyncM, we designed the first
single-SyncA-based antimicrobial. The insights gained from this work
will aid future bioengineering studies. Additionally, it broadens
SyncM′s application scope for introducing macrocycles in other
bioactive molecules.